TNBC - Triple-Negative Breast Cancer Clinical Trials in Philadelphia, Pennsylvania
3 recruitingPhiladelphia, Pennsylvania
Showing 1–3 of 3 trials
Recruiting
Phase 2
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Breast CancerBreast NeoplasmsHER2-negative Breast Cancer+6 more
QuantumLeap Healthcare Collaborative5,000 enrolled42 locationsNCT01042379
Recruiting
Role of the Immune Environment in Response to Therapy in Breast Cancer
Breast CancerHER2-negative Breast CancerER Positive Breast Cancer+1 more
Abramson Cancer Center at Penn Medicine300 enrolled1 locationNCT05396612
Recruiting
Phase 1Phase 2
Study of LP-184 in Patients With Advanced Solid Tumors
Advanced Solid TumorMetastatic Solid TumorTNBC - Triple-Negative Breast Cancer+4 more
Lantern Pharma Inc.175 enrolled9 locationsNCT05933265